AwardJun 12, 2026, 06:07 AM
Evaxion Wins Prix Galien UK Award for Best Digital Health Solution
AI Summary
Evaxion A/S, a clinical-stage TechBio company, has been awarded the 2026 Prix Galien UK Award for Best digital health solution for its AI-Immunology™ platform. This prestigious award serves as a strong external validation of the platform's innovative use of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases. This marks the second recognition from the Galien Prix Foundation in less than a year, highlighting the platform's significant scientific development and tangible impact on human health.
Key Highlights
- Evaxion received the 2026 Prix Galien UK Award for Best digital health solution.
- The award recognizes Evaxion's pioneering AI-Immunology™ platform.
- The AI-Immunology™ platform develops novel vaccine candidates for cancer and infectious diseases.
- This is the second recognition from the Galien Prix Foundation in less than a year.
- The award committee evaluated innovation, scientific development, clinical application, and impact on human health.
Price Impact
More from EVAX